Home » Stocks » MLAB

Mesa Laboratories, Inc. (MLAB)

Stock Price: $271.85 USD 4.96 (1.86%)
Updated December 4, 4:00 PM EST - Market closed

MLAB Stock Price Chart

Key Info

Market Cap 1.39B
Revenue (ttm) 127.66M
Net Income (ttm) -2.61M
Shares Out 5.11M
EPS (ttm) -0.56
PE Ratio n/a
Forward PE 35.21
Dividend $0.64
Dividend Yield 0.24%

Stock Quote

Trading Day December 4
Last Price $271.85
Previous Close $266.89
Change ($) 4.96
Change (%) 1.86%
Day's Open 267.49
Day's Range 265.18 - 273.05
Day's Volume 26,298
52-Week Range 190.33 - 289.82

MLAB Stock News

Zacks Investment Research - 1 month ago

Mesa Labs (MLAB) delivered earnings and revenue surprises of 78.50% and 5.25%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 1 month ago

LAKEWOOD, Colo., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the second quarter (“2Q21”) and six months ended September 30, 2020.

Zacks Investment Research - 1 month ago

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 2 months ago

LAKEWOOD, Colo., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a ...

Zacks Investment Research - 2 months ago

Bear of the Day: Mesa Labs (MLAB)

GuruFocus - 3 months ago

The S&P 500 index saw its trailing 12-month revenue per share increase by approximately 4% every year over the past five years.

Other stocks mentioned: AAON, AMOT
Zacks Investment Research - 3 months ago

Mesa Labs (MLAB) delivered earnings and revenue surprises of -6.18% and -5.55%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 3 months ago

LAKEWOOD, Colo., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the first quarter (“1Q21”).

Zacks Investment Research - 4 months ago

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 5 months ago

Source:  Mesa Laboratories, Inc. – June 16, 2020 11:30 AM ET

GlobeNewsWire - 5 months ago

Source: Mesa Laboratories, Inc. - June 9, 2020 8:15 PM ET

GlobeNewsWire - 5 months ago

Source: Mesa Laboratories, Inc. – June 8, 2020 4:01 PM ET

Zacks Investment Research - 6 months ago

Mesa Labs (MLAB) delivered earnings and revenue surprises of -36.45% and -0.85%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 6 months ago

Shares of Mesa Laboratories (NASDAQ:MLAB) were unchanged after the company reported Q4 results.

GlobeNewsWire - 6 months ago

LAKEWOOD, Colo., June 01, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (“4Q20”) and full year ended March 31, 2020 (“FY20”).

Zacks Investment Research - 6 months ago

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 6 months ago

LAKEWOOD, Colo., May 15, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced the election of Shannon Hall to its Board of Directors.  Shannon previously led the Li...

GlobeNewsWire - 10 months ago

LAKEWOOD, Colo., Jan. 09, 2020 (GLOBE NEWSWIRE) --  Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a re...

Zacks Investment Research - 1 year ago

Mesa Labs (MLAB) delivered earnings and revenue surprises of 0.58% and -1.79%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 1 year ago

LAKEWOOD, Colo., Oct. 31, 2019 (GLOBE NEWSWIRE) --  Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a diversified supplier of quality control instruments and co...

Zacks Investment Research - 1 year ago

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 1 year ago

Mesa Labs (MLAB) delivered earnings and revenue surprises of 7.18% and 2.29%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Seeking Alpha - 1 year ago

Mesa Laboratories Inc. is up almost 300 percent over the last 6 years.

About MLAB

Mesa Laboratories designs, manufactures, and markets quality control instruments and disposable products in the United States, Canada, Europe, and Japan. The company's Sterilization and Disinfection Control segment manufactures and markets biological indicators comprising spore strips, self-contained products, and culture media, as well as process challenge devices; and offers testing services. This segment also provides chemical and cleaning indicators that are used to assess the effectiveness of sterilization and cleaning processes. Its Instr... [Read more...]

Industry
Scientific & Technical Instruments
Founded
1982
CEO
Gary Owens
Employees
460
Stock Exchange
NASDAQ
Ticker Symbol
MLAB
Full Company Profile

Financial Performance

In 2019, MLAB's revenue was $117.69 million, an increase of 14.11% compared to the previous year's $103.14 million. Earnings were $1.35 million, a decrease of -81.97%.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for MLAB is 281.50, which is an increase of 3.55% from the latest price.

Price Target
$281.50
(3.55% upside)